Mackenzie Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Mackenzie Financial’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,252,857	Closed	-$87.2M	–	1811
2024 Q3	$87.2M	Sell	1,252,857 -6,983	-0.6%	-$479K	0.12%	153
2024 Q2	$84.7M	Sell	1,259,840 -7,535	-0.6%	-$508K	0.13%	152
2024 Q1	$87.4M	Buy	1,267,375 +17,370	+1%	+$1.17M	0.13%	153
2023 Q4	$77.8M	Buy	1,250,005 +10,872	+0.9%	+$608K	0.12%	160
2023 Q3	$68.5M	Buy	+1,239,133	New	+$69.7M	0.12%	157
2022 Q4	–	Sell	-3,053	Closed	-$215K	–	1605
2022 Q3	$215K	Buy	+3,053	New	+$211K	﹤0.01%	1219

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Mackenzie Financial's AXNX Position: Q4 2024 in Review

Mackenzie Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 1,252,857 shares — an estimated $87.2M sold.

Mackenzie Financial first reported a position in AXNX in Q3 2022 and held it in 6 quarters. The position peaked at $87.4M in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Mackenzie Financial reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Mackenzie Financial sold 1,252,857 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $87.2M.
Mackenzie Financial first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Mackenzie Financial's Axonics, Inc. Common Stock position peaked at $87.4M in Q1 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Mackenzie Financial's 13F filing for Q4 2024, filed 14 Feb 2025.